Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.

BMC medical genomics - 15 Oct 2015

Carere Deanna Alexis, VanderWeele Tyler, Moreno Tanya A, Mountain Joanna L, Roberts J Scott, Kraft Peter, Green Robert C

Abstract excerpt

BACKGROUND: Direct access to genomic information has the potential to transform cancer risk counseling. We measured the impact of direct-to-consumer genomic risk information on changes to perceived risk (ΔPR) of breast, prostate, colorectal and lung cancer among personal genomic testing (PGT) customers. We hypothesized that ΔPR would reflect directionality of risk estimates, attenuate with time, and be modified...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Lung Neoplasms

Share to Neoplasms

Share to Perception

Share to Prostatic Neoplasms

Share to Surveys and Questionnaires

Source

Open in PubMed Open full text

Identifiers

PMID: 26468061
DOI: 10.1186/s12920-015-0140-y
PMCID: PMC4606558

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.PMID 26468061Read ↗

Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study.Semantic proximity Read ↗

Direct-to-Consumer Personal Genome Testing and Cancer Risk PredictionSemantic proximity Read ↗

Impact of direct-to-consumer genomic testing at long term follow-up.Semantic proximity Read ↗

Consumer perceptions of direct-to-consumer personalized genomic risk assessments.Semantic proximity Read ↗

Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation.Semantic proximity Read ↗

Effect of direct-to-consumer genomewide profiling to assess disease risk.Semantic proximity Read ↗

Direct-to-consumer personal genomic testing: a case study and practical recommendations for “genomic counseling”.Semantic proximity Read ↗

The Breast Cancer Genetic Testing Experience: Probing the Potential Utility of an Online Decision Aid in Risk Perception and Decision MakingSemantic proximity Read ↗

The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making.Semantic proximity Read ↗

The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.Semantic proximity Read ↗

Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.Semantic proximity Read ↗

Outcomes from a Novel Approach to Studying Consumer Genetic Testing for Germline Cancer and Cardiovascular Risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.